CONTEXT THERAPEUTICS INC. Current Liabilities
CONTEXT THERAPEUTICS INC. (CNTX) had Current Liabilities of $7.88 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $7.88M.
- 2026-03-31: Liabilities, Current $6.53M.
- 2025-12-31: Liabilities, Current $8.02M.
- 2025-09-30: Liabilities, Current $6.04M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $7.88M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $6.53M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $8.02M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $6.04M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $4.56M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.90M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $2.75M 10-K · filed 2026-03-23 |
| 2024-09-30 | $2.33M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.60M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $2.61M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $4.19M 10-K · filed 2025-03-20 |
| 2023-09-30 | $4.60M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.76M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.21M 10-K · filed 2024-03-21 |
| 2022-09-30 | $4.01M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.04M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.61M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $3.03M 10-K · filed 2023-03-22 |
| 2021-09-30 | $4.41M 10-Q · filed 2021-12-02 |
| 2020-12-31 | $9.55M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |